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PhosphorylationHeat shock factor 1 (HSF1) is the master transcriptional regulator of chaperone genes. HSF1 regu-
lates the expression of the immediate-early response gene IER5, which encodes a protein that has
roles in the stress response and cell proliferation. Here, we have shown that IER5 interacts with pro-
tein phosphatase 2A (PP2A) and its B55 regulatory subunits. Expression of IER5 and B55 in cells leads
to HSF1 dephosphorylation and activation of HSF1 target genes. The B55 subunits directly bind to
HSF1. These results suggest that IER5 functions as a positive feedback regulator of HSF1 and that this
process involves PP2A/B55 and HSF1 dephosphorylation.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Mammalian heat shock factor 1 (HSF1) plays a central role in
the cellular-response to different proteotoxic conditions and regu-
lates both the constitutive and the stress-inducible expression of
heat shock protein (HSP) genes. Many HSPs function as molecular
chaperones that assist in the correct folding of nascent polypeptide
chains and prevent the formation of non-speciﬁc protein aggre-
gates [1,2]. Under non-stressful conditions, HSF1 also targets a
wide spectrum of genes involved in cell maintenance, cell cycle
progression, and differentiation, thereby playing a key role in the
processes of aging, carcinogenesis, and development [2–4].
Most HSF1 in the normal cell is present in a latent inactive
monomeric state in the cytoplasm, although a small amount of
HSF1 engages in transcriptional regulation in the nucleus. In
response to proteotoxic stress, such as heat shock, HSF1 forms a
trimer, translocates into the nucleus, binds to the heat shock ele-
ments (HSEs), and acquires transcriptional ability. The transcrip-
tional activity is modulated by protein–protein interactions andpost-translational modiﬁcations, including phosphorylation, acety-
lation, and sumoylation [5–8]. HSF1 is a phosphorylated protein
even under non-stressful conditions, and this constitutive phos-
phorylation is implicated in the repression of the transcriptional
activity [9–16]. Stress-induced hyperphosphorylation of HSF1 is a
prerequisite for acquisition of the activator function [17–20].
IER5 is a member of the growth-related immediate-early gene
family and encodes a 327-amino acids protein with putative
nuclear localization signals [21]. Expression of IER5 is rapidly and
transiently induced after stimulation of resting cells with serum,
as other immediate-early genes, and by treatment of cells with
ionizing radiation and anti-cancer agents [21–26]. IER5 is a nega-
tive regulator of cell proliferation; overexpression of IER5 leads
to G2-M cell cycle arrest, whereas IER5 knockdown increases pro-
liferation [24,25]. IER5 reduces the expression of CDC25B, a posi-
tive regulator of cell cycle progression, through direct binding to
the gene promoter, suggesting a role as a transcription factor [25].
We have recently demonstrated that IER5 is a target of HSF1 and
that its expression is induced in response to proteotoxic stress [27].
Expression of IER5 causes an increase in chaperone gene
expression and in recovery from thermal stress. It was speculated
that IER5 modulates the transcriptional activity of HSF1. In the pre-
sent study, we ﬁrst examined the effect of IER5 on the phos-
phorylation status of HSF1, then investigated the interactions of
HSF1, IER5, and the regulatory subunits of protein phosphatase
2A (PP2A).
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2.1. DNA constructs
The coding region of IER5 was cloned into the gene expression
vectors pEBMulti-Hyg (Wako Pure Chemicals, Osaka, Japan) and
pcDNA3.1(+) (Invitrogen, Carlsbad, CA, USA) to create pEBMulti-
IER5 and pcDNA-IER5, respectively [27]. For the expression of an
inﬂuenza hemagglutinin (HA)-tagged protein, the coding region
was cloned into pBK266, a derivative of pcDNA3.1(+) containing
three copies of the HA-tag sequences (pcDNA-IER5-HA) [28].
Plasmid pK732 is a derivative of pcDNA3.1(+) containing HSF1-
HA [29]. Nucleotide substitution mutations were introduced by
standard methods. The HSF1 fragment was also cloned into the glu-
tathione S-transferase (GST) gene fusion vector pGEX-6P-1 (GE
Healthcare, Buckinghamshire, UK). The cDNA of B55 family mem-
bers was ampliﬁed by RT-PCR from the total RNA of HeLa cells
and cloned into pcDNA3.1(+), pBK266, and pGEX-6P-1. The ﬁreﬂy
reporter construct HSE-SV40-LUC contained HSE4P oligonu-
cleotides upstream of the SV40 promoter of the pGL3-Promoter
vector (Promega, Madison, WI, USA) [27]. The ﬁreﬂy reporter con-
struct HSP70-LUC contained the promoter region of HSPA1A in the
pGL3-Basic vector (Promega) [27].
2.2. Cell culture and transfection
HeLa cells were cultured as described previously [28,29].
Transfection was conducted using HilyMax reagent according to
the manufacturer’s recommended protocol (Dojindo Laboratories,
Kumamoto, Japan).
2.3. Western blotting
Cell extracts were prepared and subjected to Western blotting
as described previously [27]. For phosphatase treatment and
Phos-tag SDS polyacrylamide gel electrophoresis (PAGE), cells
were lysed in high-salt buffer containing 50 mM Tris–Cl (pH 7.6),
0.42 M NaCl, 25% glycerol, 0.5 mM phenylmethylsulfonyl ﬂuoride,
and protease inhibitor cocktail (Nacarai Tesque, Kyoto, Japan).
Cell extracts were diluted 3-fold with distilled water and incubated
with 10 U of calf intestinal alkaline phosphatase at room tempera-
ture for 10 min. The 6% acrylamide gel contained 20 lM Phos-tag
(Wako Pure Chemicals) and 40 lM MnCl2, and Western blotting
was conducted according to the manufacturer’s protocol [30].
The following antibodies were used: anti-IER5 [27], anti-HSP70
[27], anti-HSF1 [27], anti-PP2A-Ca/b (Santa Cruz Biotechnology,
Santa Cruz, CA, USA), anti-HA [28], and anti-GAPDH [27].
2.4. RT-PCR assay
The RT-PCR analysis was performed as described previously
[27,28]. The PCR product quantities were compared after nor-
malizing each sample to the amounts of GAPDH PCR products.
2.5. Luciferase assay
Cells were transfected with DNA mixtures containing ﬁreﬂy
luciferase reporter plasmid, Renilla luciferase control plasmid
(pRL-TK), and gene expression plasmid [28,29]. For knockdown
experiments, small interfering RNA (siRNA) was co-transfected.
The sequences of siRNA are as follows: siIER5, sense 50-CCUCAUC
AGCAUCUUCGGUUU-30 and antisense 50-ACCGAAGAUGCUGAU
GAGGUU-30; scrambled siRNA, sense 50-CCUACGCCACCAAUUUCG
UUU-30 and antisense 50-ACGAAAUUGGUGGCGUAGGUU-30. The
luciferase assay was performed using the Dual-LuciferaseReporter Assay System (Promega) and ﬁreﬂy luciferase activity
(arbitrary units) was calculated after normalization to Renilla luci-
ferase values.
2.6. GST pull-down assay
GST fusion proteins were immobilized on glutathione-
Sepharose 4B (GE Healthcare) (Supplementary Fig. S1) [29]. IER5-
HA, B55b-HA, and HSF1 polypeptides were synthesized in vitro
using the TNT T7 Coupled Reticulocyte Lysate System (Promega).
The polypeptides were incubated with immobilized proteins in
binding buffer [29] at room temperature for 15 min. After three
washes with 200 ll of binding buffer, bound polypeptides were
subjected to Western blotting.
2.7. Immunoprecipitation and in vitro phosphatase assay
Cells were lysed in buffer containing 20 mM Tris–Cl (pH 7.6),
0.1 M NaCl, 0.5 mM EDTA, 0.5% NP-40, 0.5 mM phenylmethylsul-
fonyl ﬂuoride, and protease inhibitor cocktail. Cell extracts were
incubated with an anti-HA antibody at 4 C overnight and then
with Protein A Sepharose CL-4B (GE Healthcare) on a rotating
wheel for 90 min. Beads were washed with lysis buffer and bound
proteins were subjected to Western blotting. For the phosphatase
assay, beads were added in 100 ll of a phosphatase assay buffer
containing 50 mM Tris–Cl (pH 7.6), 1 mM MgCl2, and 1 mM 6,
8-diﬂuoro-4-methylumbelliferyl phosphate (DiFMUP, Molecular
Probes, Eugene, OR, USA). Fluorometric assay of DiFMUP substrate
was conducted using a microplate luminometer (FluoroSkan
Ascent, Thermo Scientiﬁc) as described [31].
2.8. Statistical analysis
The data are representative of at least three independent
experiments. Signiﬁcant differences were determined by
Student’s t-test.
3. Results
3.1. Effect of IER5 on the expression of HSE-containing genes
Although IER5 was suggested to contain nuclear localization
signal sequences [21], its cellular localization has not been experi-
mentally determined. We prepared cytoplasmic and nuclear
extracts from HeLa cells and analyzed for IER5 levels in both the
fractions (Fig. 1A). IER5 was present predominantly in the
cytoplasmic fraction, and the nuclear fraction contained a small
amount of IER5. Heat shock treatment of cells at 42.5 C for 1 h
did not signiﬁcantly change the cellular distribution of IER5.
Therefore, IER5 is mostly located in the cytoplasm. HSF1 was
detected in the cytoplasm in non-heat-shocked cells and translo-
cated to the nucleus during heat shock. The reason for slower
migration of HSF1 in the heat-shocked samples was hyperphos-
phorylation (see Fig. 2A) [32].
The chaperone gene HSP70 contains HSEs, and its expression is
regulated by HSF1 under both normal physiological conditions and
heat shock conditions [4]. We conducted Western blot analysis to
examine HSP70 levels in HeLa cells harboring the IER5 expression
plasmid (Fig. 1B). Forced expression of IER5 caused a 1.4-fold
increase in HSP70 in non-heat-shocked cells. When cells were
heat-shocked at 42.5 C for 1 h and allowed to recover at 37 C
for 5 h, HSP70 levels increased 1.9-fold in control cells and 2.7-fold
in cells harboring the IER5 plasmid. RT-PCR analysis showed that
the constitutive and heat-induced levels of HSP70 mRNA were
increased by IER5 (Fig. 1C). The effect of IER5 on the expression
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Fig. 2. HSF1 activity in cells expressing IER5. (A) Phosphorylation status of HSF1.
Cells transfected with the IER5-HA expression construct pcDNA-IER5-HA or empty
vector plasmid pcDNA3.1 were heat-shocked at 42.5 C for 30 min (HS) or were
untreated. Phosphatase (CIAP)-treated and untreated samples were subjected to
SDS–PAGE (left panel) and Phos-tag SDS–PAGE (right panel) followed by Western
blot analysis using anti-HSF1 and anti-GAPDH. On the SDS–PAGE, the positions of
molecular mass markers are shown on the right. On the Phos-tag SDS–PAGE,
phosphatase-treated HSF1 bands are marked by P; two HSF1 bands in control cell
samples are marked by C1 and C2, and three HSF1 bands in heat-shocked cell
samples are marked by H1, H2, and H3. (B) Schematic representation of HSF1. DNA-
binding domain (DBD), hydrophobic repeats (HR-A/B and HR-C), conserved
negative regulatory domain (CD), and four serine residues are shown. Bars show
the regions fused to GST: FL contained full length HSF1; DB (DNA-binding and
oligomerization domains) contained residues 1–202 of HSF1; RD (repression
domain) contained residues 202–397; and AD (activation domain) contained
residues 400–529. (C) Luciferase assay of HSP70-LUC in cells expressing HSF1-HA.
Fireﬂy luciferase reporter construct HSP70-LUC was transfected along with the
HSF1-HA expression constructs and pcDNA-IER5-HA or pcDNA3.1 (cont). Fireﬂy
luciferase activities (arbitrary units) are expressed as the mean ± S.D. of six
experiments. The fold increase of luciferase activity by IER5-HA cotransfection is
indicated. Asterisks indicate statistically signiﬁcant upregulation by alanine
substitution mutations compared with wild type (⁄P < 0.01). (D) Phos-tag SDS–
PAGE of HSF1-HA derivatives. Cells were transfected with the HSF1-HA expression
constructs, and extracts were subjected to Phos-tag SDS–PAGE (upper panel) and
SDS–PAGE (lower panel) followed by Western blot analysis using anti-HA and anti-
GAPDH. Two HSF1-HA bands are marked by C1 and C2. Different bands observed in
HSF1-HA containing the S303A, S307A, and S363A mutations are marked by closed
circles. (E) Phos-tag SDS–PAGE of HSF1(S363A)-HA. Cells were transfected with the
HSF1-HA expression constructs and pcDNA-IER5 or pcDNA3.1. Phosphatase (CIAP)-
treated and untreated samples were subjected to Phos-tag SDS–PAGE (upper panel)
and SDS–PAGE (lower panel) followed by Western blot analysis using anti-HA and
anti-GAPDH. Three HSF1(S363A)-HA bands are marked by C1, C10 , and C3.
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Fig. 1. Transcriptional activity of HSE-containing genes in cells expressing IER5. (A)
Western blotting of IER5. HeLa cells cultured at 37 C (NHS) were heat-shocked at
42.5 C for 1 h (HS). Cytoplasmic (C) and nuclear (N) extracts were subjected to
Western blot analysis using anti-IER5, anti-HSF1, and anti-GAPDH. The positions of
molecular mass markers are shown on the right. (B) Western blotting of HSP70.
HeLa cells were transfected with the IER5 expression construct pEBMulti-IER5 or
control empty vector plasmid pEBMulti-Hyg. The cells were heat-shocked at 42.5 C
for 1 h and allowed to recover at 37 C for 5 h (HS) or were untreated (NHS). Cell
extracts were subjected to Western blot analysis using anti-HSP70, anti-IER5, and
anti-GAPDH. The relative levels of HSP70 are indicated. (C) RT-PCR of HSP70 mRNA.
Cells transfected as in (B) were heat-shocked at 42.5 C for 1 h (HS) or were
untreated (NHS). The HSP70 mRNA levels were compared with control non-heat-
shocked cells (cont). Data are expressed as the mean ± S.D. of three experiments.
⁄P < 0.01. (D) Luciferase assay of the HSE-containing reporter gene. Fireﬂy luciferase
reporter constructs HSE-SV40-LUC (+HSE) and SV40-LUC (HSE) were transfected
along with pEBMulti-IER5 or pEBMulti-Hyg. Cells were exposed to 42.5 C for 1 h
and then recovered at 37 C for 4 h (right panel, HS) or were untreated (left panel,
NHS). Fireﬂy luciferase activities (AU: arbitrary units) are expressed as the
mean ± S.D. of four experiments. ⁄P < 0.01. (E) Luciferase assay of HSE-SV40-LUC
in IER5-silenced cells. (Left panel) Cells were transfected with IER5 siRNA or
scrambled siRNA (SCR), and extracts were subjected to Western blot analysis using
anti-IER5 and anti-GAPDH. (Right panel) Fireﬂy luciferase reporter construct HSE-
SV40-LUC was transfected along with IER5 siRNA or scrambled siRNA. Cells were
cultured as in (D). Fireﬂy luciferase activities are expressed as the mean ± S.D. of
four experiments. ⁄P < 0.01.
1152 Y. Ishikawa et al. / FEBS Letters 589 (2015) 1150–1155of the HSE-containing genes was further analyzed using synthetic
luciferase reporter constructs (Fig. 1D). Under non-heat shock con-
ditions, IER5 did not affect the luciferase activity of a reporter con-
struct, the expression of which was driven by basal promoter.
When HSE oligonucleotides were inserted upstream of the pro-
moter, the luciferase activity increased 1.5-fold in cells harboring
the IER5 plasmid. Heat shock led to robust expression of the
HSE-containing reporter, and IER5 further stimulated expression.
Conversely, silencing IER5 caused a 25% decrease in expression
Y. Ishikawa et al. / FEBS Letters 589 (2015) 1150–1155 1153of the HSE-containing reporter in heat-shocked cells (Fig. 1E). The
constitutive expression was also reduced (10%) by IER5 knock-
down, although it was not statistically signiﬁcant. Therefore, IER5
induces the expression of HSE-containing genes. Because HSE is
the recognition sequence of HSF1, it is implied that IER5 stimulates
the transcriptional ability of HSF1 under both non-heat shock and
heat shock conditions.BA
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Fig. 3. Interactions of IER5 and PP2A/B55. (A) GST pull-down analysis of IER5 and
B55. In vitro-synthesized IER5-HA polypeptides were incubated with GST or GST-
B55 (a, b, c, and d) fusions. Input (IN) and bound polypeptides were subjected to
Western blot analysis using anti-HA. (B) Co-immunoprecipitation analysis of IER5
and PP2AC. Extracts were prepared from cells transfected with pcDNA-IER5-HA or
pcDNA3.1. Immunoprecipitation was conducted using anti-HA and precipitated
proteins were subjected toWestern blot analysis using anti-PP2AC and anti-HA. The
positions of molecular mass markers are shown on the right. (C) The phosphatase
activity of IER5-containing complex. Immunoprecipitation was conducted as in (B),
and precipitated proteins were subjected to the phosphatase assay using DiFMUP as
a substrate. Okadaic acid (OA) was added to the ﬁnal concentration of 5 nM.
Phosphatase activities are given as arbitrary units (AU).3.2. Effect of IER5 on HSF1 phosphorylation
Transcriptional competence of HSF1 is regulated by its phos-
phorylation status [5,6]. Western blot analysis showed that HSF1
was phosphorylated in cells under normal physiological
conditions, as determined by its slower migration on SDS polyacry-
lamide gels relative to phosphatase-treated samples (Fig. 2A).
When cells were heat-shocked at 42.5 C for 30 min, HSF1 was
hyperphosphorylated and migrated more slowly than that of
non-heat-shocked cells. Forced expression of HA-tagged
IER5 (IER5-HA) did not affect the mobility of HSF1 in this
analysis.
The addition of Phos-tag, a phosphate-binding molecule, to the
gels results in the mobility shift of phosphorylated proteins [30].
On Phos-tag SDS–PAGE, HSF1 from non-heat-shocked cells was
detected as two bands C1 and C2, and the HSF1 of heat-shocked
cells was detected as at least three bands H1, H2, and H3
(Fig. 2A). Expression of IER5-HA led to a decrease in the intensi-
ties of C2 and H3. C2 and H3 bands migrated slowly on the gels
and would thus be more extensively phosphorylated than faster
migrating bands, implying that IER5 is involved with dephos-
phorylation of HSF1, regardless of thermal stress.
Constitutive phosphorylation of HSF1 on serine residues 121,
303, 307, and 363 is involved in repression of HSF1’s transcrip-
tional activity (Fig. 2B) [9–16]. We constructed HA-tagged HSF1
derivatives containing alanine substitution mutations in these resi-
dues and analyzed the effect of IER5 using an HSP70 promoter-dri-
ven luciferase reporter construct (HSP70-LUC) (Fig. 2C). Under non-
heat shock conditions, the luciferase activity of HSP70-LUC was
increased 4.5-fold by the co-transfection of IER5-HA. When
HSF1-HA was transfected, the luciferase activity increased 4.2-fold
and was further enhanced 2.1-fold by IER5-HA. The alanine sub-
stitution mutations of the four residues resulted in a 1.2–1.8-fold
higher transcriptional activity than wild-type HSF1-HA, suggesting
that phosphorylation of these residues leads to repression of HSF1.
In cells harboring HSF1-HA with the S121A, S303A, and S307A
mutations, IER5-HA enhanced the reporter expression 1.7–2.4-fold,
which was not statistically different from its effect in cells harbor-
ing the wild type. However, the luciferase activity of S363A mutant
cells was increased only 1.3-fold by IER5-HA. A phospho-mimetic
aspartic acid mutation at S363 (S363D) did not signiﬁcantly change
the HSF1-HA activity, and IER5-HA had a small effect (1.4-fold
increase) on the expression of the reporter. Because the effect of
IER5 was diminished by the S363A and S363D mutations, S363
should be the target residue for IER5 function. On Phos-tag SDS–
PAGE, the S303A, S307A, and S363A mutations affected the mobil-
ity of HSF1-HA (Fig. 2D). The differences in band patterns reﬂected
defective phosphorylation of S303, S307, and S363. HSF1-HA con-
taining the S363A mutation resolved into at least three bands
C10, C1, and C3 (Fig. 2E). The disappearance of C2 band in S363A
suggested the contribution of S363 phosphorylation to the forma-
tion of C2 band; however, the band pattern was different from that
of wild-type HSF1-HA upon IER5 overexpression. The intensities of
C1 and C3 bands of S363A were reduced by IER5. Therefore, IER5 is
involved in the dephosphorylation of S363 and other unknown
phosphorylated residues.3.3. Interactions of IER5 and PP2A/B55
Previous high throughput protein–protein interaction analysis
showed the binding of IER5 to the B55b subunit of PP2A [33].
PP2A is a trimeric holoenzyme of the catalytic C subunit, scaffold
A subunit, and regulatory B subunit [34,35]. B55b is a member of
the B subunits and constitutes a family together with B55a,
B55c, and B55d. The B subunit is important in the regulation of
PP2A speciﬁcity and activity. We examined the interactions of
IER5 and the B55 subunits using in vitro-synthesized IER5-HA
polypeptides and GST fusions of B55a, B55b, B55c, and B55d. The
results of GST pull-down analysis showed binding of IER5 to all
four B55 subunits (Fig. 3A).
Coimmunoprecipitation analysis was conducted to analyze the
interaction of IER5 and PP2A. As shown in Fig. 3B, immunoprecip-
itation of IER5-HA by an anti-HA antibody resulted in
coprecipitation of the PP2A catalytic subunit (PP2AC). The
immunoprecipitated complex contained phosphatase activity, as
judged by phosphatase assay using the ﬂuorogenic phosphatase
substrate DiFMUP; however, the activity was signiﬁcantly inhib-
ited by the addition of a PP2A inhibitor, Okadaic acid, at a concen-
tration of 5.0 nM (Fig. 3C). The complex prepared from heat-
shocked cells had a similar level of phosphatase activity (data
not shown). These results indicate the interactions of IER5 with
PP2A.
3.4. Effect of B55 subunits on HSF1 activity
The interactions of HSF1 and the B55 subunits were analyzed by
a GST pull-down assay (Fig. 4A). HSF1 polypeptides bound to all
four GST-B55 fusions. Conversely, B55b-HA polypeptides bound
to HSF1 in the GST fusion. The HSF1 regions required for
B55b-HA binding were located in the N-terminal DNA-binding
and oligomerization domains and the central repression domain.
The N-terminal two-thirds of HSF1 were also bound by IER5-HA
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among HSF1, IER5, and the B55 subunits.
To investigate the role of the B55 subunits in the regulation of
HSF1 transcriptional ability, subunits were expressed in cells as
HA-tagged proteins. Western blot analysis with an anti-HA anti-
body showed the expression of these proteins, although the levels
of B55a-HA were slightly lower than those of other subunits
(Fig. 4B). When cell extracts were subjected to Phos-tag
SDS–PAGE followed by Western blotting with anti-HSF1, the inten-
sities of the HSF1 C2 band were reduced by the expression of each
of the four B55 subunits. As shown in Fig. 4C, the four B55 subunits
had a stimulatory effect on HSP70-LUC expression, resulting in a
1.5–2.4-fold increase in luciferase activity. B55b-HA and IER5-HA
enhanced the reporter expression in an additive manner. On
Phos-tag SDS–PAGE, C2 band of HSF1-HA was not observed in
the extracts of cells harboring both the B55b and IER5 constructs
(Fig. 4D). These results suggest the involvement of the B55 sub-
units in dephosphorylation and activation of HSF1.
4. Discussion
HSF1 is known to induce the expression of IER5 in response to
proteotoxic stress, including heat shock [27]. Expression of IER5
leads to dephosphorylation of HSF1 on serine 363 and to induction
of HSF1 target genes, including HSP70. IER5 interacts with HSF1
and protein phosphatase PP2A. The B55 regulatory subunits of
PP2A directly bind to HSF1 and enhance HSF1 dephosphorylation
and activation. Although we failed to detect an IER5-induced
association of PP2A/B55 with HSF1, these results suggest the exis-
tence of a positive feedback loop on HSF1 activation dependent on
IER5, PP2A/B55, and HSF1 dephosphorylation.
Although treatment of cells with phosphatase inhibitors causes
activation of HSF1 [36], HSF1 has both stimulatory and inhibitory
phosphorylation sites. Constitutive phosphorylation on residues
S121, S303, S307, and S363 is involved in the repression of tran-
scriptional activity, whereas stress-induced phosphorylation on
other residues is necessary for the activator function [9–20].
Phosphorylation status is determined by the balance between
phosphorylating kinases and dephosphorylating phosphatases.
Although various protein kinases are suggested to participate in
HSF1 phosphorylation, it remains unknown whether HSF1 is
dephosphorylated by a speciﬁc phosphatase. Our observation that
the B55 subunits physically interact with HSF1 and that B55
expression leads to HSF1 dephosphorylation suggests the direct
involvement of PP2A/B55 in the dephosphorylation of HSF1. Inyeast, inhibitory phosphorylation is relieved by Ppt1 phosphatase
for the ethanol-speciﬁc activation of Hsf1 [37]. Ppt1 is related to
human PP5, and PP5 physically interacts with the HSF1–Hsp90
complexes in a Xenopus oocyte model system, in which PP5 is
involved in the inhibition, but not the activation, of HSF1, although
it has not been tested whether PP5 affects the phosphorylation sta-
tus of HSF1 [38]. Meanwhile, PP2A is known to indirectly activate
HSF1. The PP2A complex containing the B56d subunit dephos-
phorylates AMP-activated protein kinase (AMPK), and inactive/
dephosphorylated AMPK is unable to phosphorylate the inhibitory
phosphorylation site S303 and causes HSF1 activation [39]. Overall,
phosphatase is a crucial regulator of HSF1.
Our observations implicate IER5 as a positive feedback regulator
of HSF1. We propose that IER5 induced by growth factors, heat
shock, ionizing radiation, and chemotherapy modulates cell pro-
liferation, the proteotoxic stress response, and the DNA damage
response through the regulation of HSF1.
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